Fatal antimalarial-induced cardiomyopathy: Report of 2 cases

Journal of Clinical Rheumatology

Volumn 18, Issue 7, 2012, Pages 363-366

  Azimian, Morteza ^a   Gultekin, Sakir H ^b   Hata, Jessica L ^a   Atkinson, James B ^a   Ely, Kim A ^a   Fuchs, Howard A ^a   Mobley, Bret C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

autophagy; cardiomyopathy; hydroxychloroquine; myopathy

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE; PREDNISONE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CARDIOMEGALY; CARDIOMYOPATHY; CASE REPORT; CHRONIC KIDNEY DISEASE; CONGESTIVE CARDIOMYOPATHY; DEVICE THERAPY; DISCOID LUPUS ERYTHEMATOSUS; DIZZINESS; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSPNEA; ELECTROMYOGRAPHY; ELECTRON MICROSCOPY; FAINTNESS; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE BIOPSY; HUMAN; MUSCLE WEAKNESS; PACEMAKER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SICK SINUS SYNDROME; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANTIMALARIALS; ARTHRITIS, RHEUMATOID; CARDIOMYOPATHIES; CHLOROQUINE; FATAL OUTCOME; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED;

EID: 84867803263     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31826852db     Document Type: Article

References (16)

1. Fox R. Anti-malarial drugs: possible mechanisms of action in auto-immune disease and prospects for drug development. Lupus. 1996;5(Suppl):4-10.
2. Kyburz D, Brentano F, Gay S. Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling. Nat Clin Pract Rheumatol. 2006;2:458-459. (Pubitemid 44340417)
3. Kuncl RW, Wiggins WW. Toxic myopathies. Neurol Clin. 1988;6:593-619.
4. Casado E, Gratacós J, Tolosa C, et al. Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis. 2006;65:385-390. (Pubitemid 43268230)
5. Kwon JB, Kleiner A, Ishida K, et al. Hydroxychloroquine-induced myopathy. J Clin Rheumatol. 2010;16:28-31.
6. Bolaños-Meades J, Zhou L, Hoke A, et al. Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease. Am J Hematol. 2005;78:306-309. (Pubitemid 40471125)
7. Manohar VA, Moder KG, Edwards WD, et al. Restrictive cardiomyopathy secondary to hydroxychloroquine therapy. J Rheumatol. 2009;36:440-441.
8. Nord JE, Shah PK, Rinaldi RZ, et al. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature. Semin Arthritis Rheum. 2004;33:336-351. (Pubitemid 38496042)
9. Grumati P, Coletto L, Sandri M, et al. Autophagy induction rescues muscular dystrophy. Autophagy. 2011;7:426-428.
10. Harris J. Autophagy and cytokines. Cytokine. 2011;56:140-144.
11. Sarkar S, Floto RA, Berger Z, et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol. 2005;170:1101-1111. (Pubitemid 41362642)
12. Xiong N, Jia M, Chen C, et al. Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y. Neuroscience. 2011;199:292-302.
13. Soong TR, Barouch LA, Champion HC, et al. New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathyVa report of 2 cases. Hum Pathol. 2007;38:1858-1863. (Pubitemid 350179936)
14. Costedoat-Chalumeau N, Hulot JS, Amoura Z, et al. Cardiomyopathy related to antimalarial therapy with illustrative case report. Cardiology. 2007;107:73-80.
15. Siddiqui AK, Huberfeld SI, Weidenheim KM, et al. Hydroxychloroquine- induced toxic myopathy causing respiratory failure. Chest. 2007;131:588-590. (Pubitemid 46280423)
16. Cotroneo J, Sleik KM, Rene Rodriguez E, et al. Hydroxychloroquine-induced restrictive cardiomyopathy. Eur J Echocardiogr. 2007;8:247-251.